Pharmaceutical raw materials used in synthesizing new medications

chemical-categories

NQTrp LAB GRADE 97%

A novel inhibitor of Aβ oligomer and fibril formation (IC50 = 50 nM for formation of fibrils from Aβ1-42)

http://www.bocsci.com/nqtrp-cas-185351-19-3-item-452793.html

Properties Suppliers
NRTN (Neurturin), Human LAB GRADE 97%

Creative peptides is specialized in the process development and the manufacturing of bioactive peptides. We offer custom peptide synthesis, process development, GMP manufacturing as well as catalog products. We supply NRTN (Neurturin), Human. More information please visit the website: http://www.creative-peptides.com/product/nrtn-neurturin-human-item-gr2111-32505.html

Properties Suppliers
NUAK family SNF1-like kinase 2 (446-455) LAB GRADE 97%

Creative peptides is specialized in the process development and the manufacturing of bioactive peptides. We offer custom peptide synthesis, process development, GMP manufacturing as well as catalog products. We supply NUAK family SNF1-like kinase 2 (446-455).http://www.creative-peptides.com/product/nuak-family-snf1-like-kinase-item-ta-175-12480.html

Properties Suppliers
NY-CO-13 (139-147) LAB GRADE 97%

Creative peptides is specialized in the process development and the manufacturing of bioactive peptides. We offer custom peptide synthesis, process development, GMP manufacturing as well as catalog products. We supply NY-CO-13 (139-147).http://www.creative-peptides.com/product/ny-co-item-ta-093-4224.html

Properties Suppliers
NY-CO-13(187-197) LAB GRADE 97%

Creative peptides is specialized in the process development and the manufacturing of bioactive peptides. We offer custom peptide synthesis, process development, GMP manufacturing as well as catalog products. We supply NY-CO-13(187-197).http://www.creative-peptides.com/product/ny-co-item-ta-088-3367.html

Properties Suppliers
NY-ESO-1 (155-163) LAB GRADE 97%

Creative peptides is specialized in the process development and the manufacturing of bioactive peptides. We offer custom peptide synthesis, process development, GMP manufacturing as well as catalog products. We supply NY-ESO-1 (155-163).http://www.creative-peptides.com/product/ny-eso-item-ta-039-1048.html

Properties Suppliers
NY-ESO-1 (157-165) LAB GRADE 97%

Creative peptides is specialized in the process development and the manufacturing of bioactive peptides. We offer custom peptide synthesis, process development, GMP manufacturing as well as catalog products. We supply NY-ESO-1 (157-165).http://www.creative-peptides.com/product/ny-eso-item-ta-009-369.html

Properties Suppliers
NY-ESO-1 (161-180) LAB GRADE 97%

Creative peptides is specialized in the process development and the manufacturing of bioactive peptides. We offer custom peptide synthesis, process development, GMP manufacturing as well as catalog products. We supply NY-ESO-1 (161-180).http://www.creative-peptides.com/product/ny-eso-item-ta-027-642.html

Properties Suppliers
NY-ESO-1 peptide LAB GRADE 97%

Creative peptides is specialized in the process development and the manufacturing of bioactive peptides. We offer custom peptide synthesis, process development, GMP manufacturing as well as catalog products. We supply NY-ESO-1 peptide.http://www.creative-peptides.com/product/ny-eso-peptide-item-ta-012-485.html

Properties Suppliers
Nafarelin LAB GRADE 97%

We provide Nafarelin. More information please visit the website:http://www.creative-peptides.com/product/nafarelin-acetate-item-10-101-24-76.html

CAT#
10-101-24
Synonyms/Alias
(D-2-Nal6)-LHRH; RS-94991-298; Synarel; Nafarelinum; Nafarelina; Nafarelin; Nafarelin acetate; LS-88237
CAS No.
76932-56-4 (net)
Sequence
Pyr-His-Trp-Ser-Tyr-D-2-Nal-Leu-Arg-Pro-Gly-NH2 acetate salt
M.W/Mr.
1322.5
Molecular Formula
C10H18N2O7
Source
Synthetic
Long-term Storage Conditions
−20°C
Application
Nafarelin acetate is a potent synthetic agonist of gonadotropin-releasing hormone. Nafarelin has been used in the treatments of central precocious puberty and endometriosis.
Description
Nafarelin acetate is a potent LHRH agonist. After a transient increase, continuous administration results in downregulation of LH and FSH levels followed by a suppression of ovarian and testicular steroid biosynthesis.
Areas of Interest
Hormonal therapy

 

Properties Suppliers